MYO - Myomo A High Risk And High Potential Investment At The Right Time
- Myomo develops, manufactures, and sells a wearable medical device for stroke patients that lost control or strength in their arms.
- Myomo's recent quarter and future growth prospects look bright in part because they received the Medicare Certification.
- They are overhauling their marketing and sales effort at a good time.
- Their expansion to the European, especially German and Chinese markets, will show results in 2021.
- A small-cap medical wearable company with a clear product portfolio, a clear strategy, and big potential.
For further details see:
Myomo, A High Risk And High Potential Investment At The Right Time